CHEK2, a protein kinase activated in response to DNA damage, is involved in cell cycle arrest, and heterozygous germline mutations in this gene have been reported in patients with Li-Fraumeni syndrome-2 [25]. This evidence concerns the gene CHEK2 and Li-Fraumeni syndrome.